Ordinary Adjustment | Solactive Global Health Services & Technology Americas | Effective Date 15th April 2025
Solactive Global Health Services & Technology Americas:
In the ordinary adjustment, the following composition will be implemented effective open 15th April 2025:
ABBOTT LABORATORIES |
ABBVIE INC |
AGILENT TECHNOLOGIES INC |
AMEDISYS INC |
AMGEN INC |
ARTIVION INC |
BAXTER INTL. |
BECTON DICKINSON AND CO |
BIOGEN INC |
BIOMARIN PHARMACEUTICAL INC |
BOSTON SCIENTIFIC CORP |
BRISTOL-MYERS SQUIBB CO |
CHEMED CORP |
DANAHER CORP |
EDWARDS LIFESCIENCES CORP |
ELEVANCE HEALTH INC |
ENCOMPASS HEALTH CORP |
ENSIGN GROUP INC |
GE HEALTHCARE TECHNOLOGIES INC |
GILEAD SCIENCES INC |
GLOBUS MEDICAL INC |
HOLOGIC INC |
INNOVIVA INC |
INTEGER HOLDINGS CORP |
JAZZ PHARMACEUTICALS PLC |
JOHNSON & JOHNSON |
LABCORP HOLDINGS INC |
MEDTRONIC PLC |
MERCK & CO. INC. |
MERIT MEDICAL SYSTEMS INC |
METTLER-TOLEDO INTL |
NATIONAL HEALTHCARE CORP |
PFIZER INC |
QIAGEN NV |
QUEST DIAGNOSTICS INC |
RESMED INC |
ROIVANT SCIENCES LTD |
STERIS PLC |
STRYKER CORP |
THERMO FISHER SCIENTIFIC INC |
ZIMMER BIOMET HOLDINGS INC |
ZOETIS INC |